Showing results (271-280 of 403) with videos related to
Sort By:
Pageof 41
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 11, 2018
Extracellular esterase activity as an indicator of endoplasmic reticulum calcium depletionKathleen A Trychta, Emily J Heathward, Agnieszka Sulima, et al.Psychopharmacology|March 30, 2007
Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonistsGregory T Collins, Amy Hauck Newman, Peter Grundt, et al.Analytical and Bioanalytical Chemistry|December 18, 2015
A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuseOscar B Torres, Joshua F G Antoline, Fuying Li, et al.Biorxiv : the Preprint Server for Biology|February 14, 2024
Cardiovascular and Locomotor Effects of Binary Mixtures of Common "Bath Salts" Constituents: Studies with Methylone, MDPV, and Caffeine in RatsRobert W Seaman, David G Galindo, Benjamin T Stinson, et al.Endocrinology|July 8, 2015
Toll-Like Receptor 4 Is an Essential Upstream Regulator of On-Time Parturition and Perinatal Viability in MiceHanan H Wahid, Camilla L Dorian, Peck Yin Chin, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 24, 2008
The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinkingValentina Sabino, Pietro Cottone, Yu Zhao, et al.Journal of Medicinal Chemistry|September 6, 2002
Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporterThomas Prisinzano, Elisabeth Greiner, Edward M Johnson, et al.The Journal of Pharmacology and Experimental Therapeutics|March 28, 2003
Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatmentEva V Varga, Marc K Rubenzik, Dagmar Stropova, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 12, 2015
Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's diseaseCheng Zhang, Ching-Chang Kuo, Setareh H Moghadam, et al.Journal of Medicinal Chemistry|April 4, 2003
Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazineElisabeth Greiner, Thomas Prisinzano, Edward M Johnson, et al.Pageof 41